UPDATE OF THE TOPICAL TREATMENT OF PSORIASIS

被引：23

作者：

Carrascosa, J. M. ^{[1
]}

Vanaclocha, F. ^{[2
]}

Borrego, L. ^{[3
]}

Fernandez-Lopez, E. ^{[4
]}

Fuertes, A. ^{[5
]}

Rodriguez-Fernandez-Freire, L. ^{[6
]}

Zulaica, A. ^{[7
]}

Tuneu, A. ^{[8
]}

Caballe, G. ^{[9
]}

Colome, E. ^{[9
]}

Bordas, X. ^{[10
]}

Hernanz, J. M. ^{[11
]}

Brufau, C. ^{[12
]}

Herrera, E. ^{[13
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, Serv Dermatol, Barcelona 08916, Spain

[2] Hosp 12 Octubre, Serv Dermatol, Madrid, Spain

[3] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain

[4] Hosp Univ Salamanca, Serv Dermatol, Salamanca, Spain

[5] Hosp Univ Dr Peset, Serv Dermatol, Valencia, Spain

[6] Hosp Univ Sevilla, Serv Dermatol, Seville, Spain

[7] Complejo Hosp Univ Vigo, Serv Dermatol, Vigo, Spain

[8] Hosp Donostia San Sebastian, San Sebastian, Spain

[9] LEO Pharma, Barcelona, Spain

[10] Ciutat Univ Bellvitge, Barcelona, Spain

[11] Hosp Infanta Leonor, Secc Dermatol, Madrid, Spain

[12] Hosp Gen Univ Reina Sofia, Secc Dermatol, Murcia, Spain

[13] Hosp Clin, Secc Dermatol, Malaga, Spain

来源：

ACTAS DERMO-SIFILIOGRAFICAS | 2009年 / 100卷 / 03期

关键词：

psoriasis; topical treatment; therapy;

D O I：

10.1016/S0001-7310(09)70534-4

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Topical therapy continues to be one of the pillars of psoriasis management. Topical corticosteroids and vitamin D analogs are the drugs of choice during the induction phase, and vitamin D analogs continue to be drugs of choice for maintenance therapy. Tazarotene and dithranol are suitable options in patients with certain, specific characteristics. The calcineurin inhibitors can be considered to be second-line treatment for psoriasis of the face and flexures. The efficacy and safety of the fixed-dose combination of betamethasone and calcipotriol in the induction phase is greater than that of either drug alone. The combination of corticosteroids with salicylic acid achieves better results than corticosteroids in monotherapy. None of the drugs evaluated stands out over the others in all clinical situations, and their use must therefore be individualized in each patient and adjusted according to the course of the disease.

引用

页码：190 / 200

页数：11

共 50 条

[31] TOPICAL EICOSAPENTAENOIC ACID IN THE TREATMENT OF PSORIASIS
OVERHOLT, MT
ORENGO, IF
BLACK, HS
HARRIS, AO
WOLF, JE
CLINICAL RESEARCH, 1990, 38 (04): : A963 - A963
[32] Topical Tacrolimus for the Treatment of Psoriasis vulgaris
Wohlrab, J.
Neubert, R.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (04): : 379 - 379
[33] TOPICAL CYCLOSPORINE IS INEFFECTIVE IN THE TREATMENT OF PSORIASIS
DELFINO, M
BRUNETTI, B
FABBROCINI, G
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (12) : 895 - 895
[34] Evaluation of topical drug treatment in psoriasis
van de Kerkhof, PCM
Steegers-Theunissen, RPM
Kuipers, MV
DERMATOLOGY, 1998, 197 (01) : 31 - 36
[35] Pharmacogenetics of topical and systemic treatment of psoriasis
Prieto-Perez, Rocio
Cabaleiro, Teresa
Dauden, Esteban
Ochoa, Dolores
Roman, Manuel
Abad-Santos, Francisco
PHARMACOGENOMICS, 2013, 14 (13) : 1623 - 1634
[36] TOPICAL USE OF FLUOROURACIL IN TREATMENT OF PSORIASIS
LJUNGGREN, B
ARCHIVES OF DERMATOLOGY, 1972, 106 (02) : 263 - +
[37] Topical Tretinoin in the Treatment of Nail Psoriasis
Grover, Chander
Daulatabad, Deepashree
INDIAN DERMATOLOGY ONLINE JOURNAL, 2022, 13 (01) : 126 - 127
[38] TOPICAL METHOXSALEN AND BLACKLIGHT IN TREATMENT OF PSORIASIS
PETROZZI, JW
KAIDBEY, KM
KLIGMAN, AM
ARCHIVES OF DERMATOLOGY, 1977, 113 (03) : 292 - 296
[39] TOPICAL CYCLOSPORINE-A IN THE TREATMENT OF PSORIASIS
SCHAUDER, CS
GORSULOWSKY, DC
CLINICAL RESEARCH, 1986, 34 (04): : 1007 - 1007
[40] Topical clobetasol propionate in the treatment of psoriasis
Feldman, Steven
Yentzer, Brad
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB140 - AB140

← 1 2 3 4 5 →